Remedium Lifecare has informed that after considering the recommendation and report of the Audit Committee and the Committee of Independent Directors, the Board of Directors of the Company at the meeting held on December 16, 2022 have considered and approved Scheme of merger of MVK Lifesciences with the Company pursuant to Sections 230 to 232 of the Companies Act, 2013 (‘Scheme’). The Scheme is subject to receipt of requisite statutory and regulatory approvals including that of shareholders and creditors of each of the Companies, as may be required, BSE and Hon’ble National Company Law Tribunal, Mumbai Bench. The Scheme shall be filed with the Stock Exchanges in terms of the provisions of Regulation 37 (1) of SEBI (LODR) Regulations, 2015 in due course. The details pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, read with the SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 in respect of the Scheme is enclosed.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Redington | 194.45 |
Adani Enterprises | 2946.15 |
Amrapali Industries | 17.63 |
Rashi Peripheral | 396.00 |
Compuage Infocom | 2.98 |
View more.. |